Camille Megy-Piro
Montpellier, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Pasteurization temperatures effectively inactivate Rift Valley fever viruses in milk.
Journal: Journal of virology
Published: January 30, 2025
Rift Valley fever virus is able to cross the human blood-brain barrier in vitro by direct infection with no deleterious effects.
Journal: Journal of virology
Published: September 30, 2024
Evidence for circulation of Rift Valley fever virus in wildlife and domestic animals in a forest environment in Gabon, Central Africa.
Journal: PLoS neglected tropical diseases
Published: October 27, 2023
Rift Valley fever virus modulates apoptosis and immune response during infection of human astrocytes.
Journal: Emerging microbes & infections
Published: June 12, 2023
Dominant mutations in mtDNA maintenance gene SSBP1 cause optic atrophy and foveopathy.
Journal: The Journal of clinical investigation
Published: February 28, 2019
OPA1 gene therapy prevents retinal ganglion cell loss in a Dominant Optic Atrophy mouse model.
Journal: Scientific reports
Published: August 23, 2017
A dominant mutation in MAPKAPK3, an actor of p38 signaling pathway, causes a new retinal dystrophy involving Bruch's membrane and retinal pigment epithelium.
Journal: Human molecular genetics
Published: October 06, 2015
Recessive Mutations in RTN4IP1 Cause Isolated and Syndromic Optic Neuropathies.
Journal: American journal of human genetics
Published: May 06, 2015
Mutation in NDUFA13/GRIM19 leads to early onset hypotonia, dyskinesia and sensorial deficiencies, and mitochondrial complex I instability.
Journal: Human molecular genetics
Published: March 16, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026